During the past decade, Centre Hospitalier de Meaux conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 2 clinical trials were completed, i.e. on average, 4.8% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 2 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier de Meaux" #1 sponsor was "The Lymphoma Academic Research Organisation" with 10 trials, followed by "Groupe Francophone des Myelodysplasies" with 7 trials sponsored, "Intergroupe Francophone de Cancerologie Thoracique" with 7 trials sponsored, "Federation Francophone de Cancerologie Digestive" with 6 trials sponsored and "Versailles Hospital" with 6 trials sponsored. Other sponsors include 48 different institutions and companies that sponsored additional 44 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier de Meaux" #1 collaborator was "Amgen" with 4 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 3 trials as a collaborator, "UNICANCER" with 3 trials as a collaborator, "Federation Francophone de Cancerologie Digestive" with 2 trials as a collaborator and "Groupe Francais De Pneumo-Cancerologie" with 2 trials as a collaborator. Other collaborators include 50 different institutions and companies that were collaborators in the rest 54 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier de Meaux" are "Multiple Myeloma" (6 trials), "Carcinoma, Non-Small-Cell Lung" (3 trials), "MDS" (3 trials), "Myelodysplastic Syndromes" (3 trials) and "Non-small Cell Lung Cancer" (3 trials). Many other conditions were trialed in "Centre Hospitalier de Meaux" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier de Meaux" are "Drug" (59 trials), "Other" (15 trials), "Procedure" (5 trials), "Biological" (4 trials) and "Radiation" (4 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (5 trials), "Cyclophosphamide" (3 trials), "Gemcitabine" (3 trials), "Lenalidomide" (3 trials) and "fluorouracil" (3 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier de Meaux" are 88 trials for "All" genders.

Currently, there are NaN active trials in "Centre Hospitalier de Meaux". undefined are not yet recruiting, 16 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 55 completed trials in Centre Hospitalier de Meaux, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier de Meaux, 5 "Phase 1" clinical trials were conducted, 28 "Phase 2" clinical trials and 33 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 13 trials that are defined as “Not Applicable".